Clinical Trial Update: Open Label Immunotherapy Trial of Inoperable Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

An open-label immunotherapy trial for inoperable pancreatic cancer is underway (Phase 1/Phase 2). Current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Immunitor LLC

Snippet

Sponsor: Immunitor LLC | Conditions: Pancreatic Cancer Non-resectable | Phase 1, Phase 2 | Status: UNKNOWN